Serum concentration of cardiac Troponin T in patients with hypereosinophilic syndrome treated with imatinib is predictive of adverse outcomes

Blood. 2003 Nov 1;102(9):3456-7; author reply 3457. doi: 10.1182/blood-2003-07-2393.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Benzamides
  • Humans
  • Hypereosinophilic Syndrome / blood*
  • Hypereosinophilic Syndrome / drug therapy
  • Imatinib Mesylate
  • Middle Aged
  • Piperazines / therapeutic use*
  • Predictive Value of Tests
  • Prognosis
  • Pyrimidines / therapeutic use*
  • Treatment Outcome
  • Troponin T / blood*

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Troponin T
  • Imatinib Mesylate